PER
Click for more information
1.22% 8.1¢ percheron therapeutics limited

per-chart, page-840

  1. Uboy
    4,683 Posts.
    lightbulb Created with Sketch. 1086
    clock Created with Sketch.
    13/06/24
    10:42
    Post #: 74293365
    Interesting - so what does this say about Sarepta’s Gene Therapy program?

    Someone at Sarepta must have photos of FDA staff - how on earth did FDA approve Sarepta given the functional results!

    PER is in a good place now on the combination therapy front, but question remains if one of the big Gorilla’s will want it all to themselves?

    Great 6 months ahead - hopefully with real value accretion.

    .
    PER Price at posting: 8.6¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 24  Upvote
    lightbulb Created with Sketch. 3  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
RMS Ramelius boosts WA gold portfolio with stake in Spartan
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢ 		Change
-0.001(1.22%) 		Mkt cap ! $73.02M
Open High Low Value Volume
8.0¢ 8.3¢ 8.0¢ $52.59K 651.3K

Buyers (Bids)

No. Vol. Price($)
1 56645 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 109832 2
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.